Education
About Us
Working with TipRanks
Follow Us
TOT BIOPHARM International Co. Ltd. (HK:1875)
:1875
RESEARCH TOOLSreports
1875 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$0.70 - HK$2.94
Previous CloseN/A
Volume400.00
Average Volume (3M)514.55K
Market Cap
HK$1.61B
Enterprise ValueHK$1.44B
Total Cash (Recent Filing)HK$381.26M
Total Debt (Recent Filing)HK$395.47M
Price to Earnings (P/E)198.1
Beta0.56
Next Earnings
Mar 24, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding772,787,900
10 Day Avg. Volume793,131
30 Day Avg. Volume514,550
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$3.00Price Target Upside44.23% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
TOT BIOPHARM International Co. Ltd. News
1875 FAQ
What was TOT BIOPHARM International Co. Ltd.’s price range in the past 12 months?
TOT BIOPHARM International Co. Ltd. lowest stock price was HK$0.70 and its highest was HK$2.94 in the past 12 months.
What is TOT BIOPHARM International Co. Ltd.’s market cap?
TOT BIOPHARM International Co. Ltd.’s market cap is HK$1.61B.
When is TOT BIOPHARM International Co. Ltd.’s upcoming earnings report date?
TOT BIOPHARM International Co. Ltd.’s upcoming earnings report date is Mar 24, 2026 which is in 186 days.
How were TOT BIOPHARM International Co. Ltd.’s earnings last quarter?
TOT BIOPHARM International Co. Ltd. released its earnings results on Aug 12, 2025. The company reported HK$0.011 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.011.
Is TOT BIOPHARM International Co. Ltd. overvalued?
According to Wall Street analysts TOT BIOPHARM International Co. Ltd.’s price is currently Undervalued.
Does TOT BIOPHARM International Co. Ltd. pay dividends?
TOT BIOPHARM International Co. Ltd. does not currently pay dividends.
What is TOT BIOPHARM International Co. Ltd.’s EPS estimate?
TOT BIOPHARM International Co. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does TOT BIOPHARM International Co. Ltd. have?
TOT BIOPHARM International Co. Ltd. has 772,787,900 shares outstanding.
What happened to TOT BIOPHARM International Co. Ltd.’s price movement after its last earnings report?
TOT BIOPHARM International Co. Ltd. reported an EPS of HK$0.011 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -3.113%.
Which hedge fund is a major shareholder of TOT BIOPHARM International Co. Ltd.?
Currently, no hedge funds are holding shares in HK:1875
TOT BIOPHARM International Co. Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
10.63%
12-Months-Change
Fundamentals
Return on Equity
0.99%
Trailing 12-Months
Asset Growth
3.34%
Trailing 12-Months
Company Description
TOT BIOPHARM International Co. Ltd.
TOT BIOPHARM International Co. Ltd. (1875) is a leading biopharmaceutical company based in China, specializing in the research, development, manufacturing, and commercialization of oncology drugs and therapies. The company's core focus is on innovative biologics and biosimilars aimed at treating various forms of cancer. With a commitment to improving patient outcomes, TOT BIOPHARM leverages advanced technologies and strategic partnerships to deliver high-quality, affordable treatments.
Technical Analysis
Mabpharm Limited
―
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H
―
Zhaoke Ophthalmology Ltd.
―
Immunotech Biopharm Ltd
―
Hightide Therapeutics Inc
―